168 related articles for article (PubMed ID: 19631369)
1. Involvement of Akt, Ras and cell cycle regulators in the potential development of endometrial hyperplasia in women with polycystic ovarian syndrome.
Villavicencio A; Goyeneche A; Telleria C; Bacallao K; Gabler F; Fuentes A; Vega M
Gynecol Oncol; 2009 Oct; 115(1):102-107. PubMed ID: 19631369
[TBL] [Abstract][Full Text] [Related]
2. Androgen and estrogen receptors and co-regulators levels in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
Villavicencio A; Bacallao K; Avellaira C; Gabler F; Fuentes A; Vega M
Gynecol Oncol; 2006 Oct; 103(1):307-14. PubMed ID: 16677694
[TBL] [Abstract][Full Text] [Related]
3. Deregulation of tissue homeostasis in endometria from patients with polycystic ovarian syndrome with and without endometrial hyperplasia.
Villavicencio A; Bacallao K; Gabler F; Fuentes A; Albornoz J; Casals A; Vega M
Gynecol Oncol; 2007 Feb; 104(2):290-5. PubMed ID: 17030058
[TBL] [Abstract][Full Text] [Related]
4. Levels of Regulatory Proteins Associated With Cell Proliferation in Endometria From Untreated Patients Having Polycystic Ovarian Syndrome With and Without Endometrial Hyperplasia.
Bacallao K; Plaza-Parrochia F; Cerda A; Gabler F; Romero C; Vantman D; Vega M
Reprod Sci; 2016 Feb; 23(2):211-8. PubMed ID: 26239387
[TBL] [Abstract][Full Text] [Related]
5. In situ estrogen metabolism in proliferative endometria from untreated women with polycystic ovarian syndrome with and without endometrial hyperplasia.
Bacallao K; Leon L; Gabler F; Soto E; Romero C; Valladares L; Vega M
J Steroid Biochem Mol Biol; 2008 May; 110(1-2):163-9. PubMed ID: 18467089
[TBL] [Abstract][Full Text] [Related]
6. Lower expression of ER-α36 is associated with the development of endometrial hyperplasia in PCOS patients.
Lin SL; Tu BB; Du XG; Yan LY; Qiao J
Histol Histopathol; 2013 Nov; 28(11):1491-8. PubMed ID: 23690166
[TBL] [Abstract][Full Text] [Related]
7. [Activation and significance of the PI3K/Akt pathway in endometrium with polycystic ovary syndrome patients].
Zhang HY; Zhang YF; Han YK; Xue FX; Zhao XH; Zhang XL
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):19-23. PubMed ID: 22455688
[TBL] [Abstract][Full Text] [Related]
8. Expression of molecules associated with tissue homeostasis in secretory endometria from untreated women with polycystic ovary syndrome.
Avellaira C; Villavicencio A; Bacallao K; Gabler F; Wells P; Romero C; Vega M
Hum Reprod; 2006 Dec; 21(12):3116-21. PubMed ID: 17008325
[TBL] [Abstract][Full Text] [Related]
9. p27, cyclin E, and CDK2 expression in normal and cancerous endometrium.
Oshita T; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2002 Oct; 21(4):737-43. PubMed ID: 12239611
[TBL] [Abstract][Full Text] [Related]
10. Implication of malignancy and prognosis of p27(kip1), Cyclin E, and Cdk2 expression in epithelial ovarian tumors.
Sui L; Dong Y; Ohno M; Sugimoto K; Tai Y; Hando T; Tokuda M
Gynecol Oncol; 2001 Oct; 83(1):56-63. PubMed ID: 11585414
[TBL] [Abstract][Full Text] [Related]
11. The role of androst-5-ene-3β,17β-diol (androstenediol) in cell proliferation in endometrium of women with polycystic ovary syndrome.
Plaza-Parrochia F; Bacallao K; Poblete C; Gabler F; Carvajal R; Romero C; Valladares L; Vega M
Steroids; 2014 Nov; 89():11-9. PubMed ID: 25065586
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of steroid receptors, coregulators, and molecules associated with uterine receptivity in secretory endometria from untreated women with polycystic ovary syndrome.
Quezada S; Avellaira C; Johnson MC; Gabler F; Fuentes A; Vega M
Fertil Steril; 2006 Apr; 85(4):1017-26. PubMed ID: 16580389
[TBL] [Abstract][Full Text] [Related]
13. Expression of steroid receptors and proteins related to apoptosis in endometria of women with polycystic ovary syndrome.
Maliqueo M; Clementi M; Gabler F; Johnson MC; Palomino A; Sir-Petermann T; Vega M
Fertil Steril; 2003 Sep; 80 Suppl 2():812-9. PubMed ID: 14505758
[TBL] [Abstract][Full Text] [Related]
14. Differential Expression Patterns of Glycolytic Enzymes and Mitochondria-Dependent Apoptosis in PCOS Patients with Endometrial Hyperplasia, an Early Hallmark of Endometrial Cancer,
Wang T; Zhang J; Hu M; Zhang Y; Cui P; Li X; Li J; Vestin E; Brännström M; Shao LR; Billig H
Int J Biol Sci; 2019; 15(3):714-725. PubMed ID: 30745857
[TBL] [Abstract][Full Text] [Related]
15. Protein expression of PKCZ (Protein Kinase C Zeta), Munc18c, and Syntaxin-4 in the insulin pathway in endometria of patients with polycystic ovary syndrome (PCOS).
Rivero R; Garin CA; Ormazabal P; Silva A; Carvajal R; Gabler F; Romero C; Vega M
Reprod Biol Endocrinol; 2012 Mar; 10():17. PubMed ID: 22390153
[TBL] [Abstract][Full Text] [Related]
16. High level of visfatin and the activation of Akt and ERK1/2 signaling pathways are associated with endometrium malignant transformation in polycystic ovary syndrome.
Tian W; Zhang H; Zhang Y; Wang Y; Zhang Y; Xue F; Song X; Zhang H
Gynecol Endocrinol; 2020 Feb; 36(2):156-161. PubMed ID: 31452406
[TBL] [Abstract][Full Text] [Related]
17. Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia.
Fornes R; Ormazabal P; Rosas C; Gabler F; Vantman D; Romero C; Vega M
Mol Med; 2010 Mar; 16(3-4):129-36. PubMed ID: 20011249
[TBL] [Abstract][Full Text] [Related]
18. [Extracellular signal-regulated protein kinase activation in endometrium with polycystic ovary syndrome and its significance].
Song XR; Zhang HY; Zhang YF; Han YK; Li KJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):767-71. PubMed ID: 21176559
[TBL] [Abstract][Full Text] [Related]
19. Involvement of cyclin-dependent kinase inhibitor p27Kip1 in growth inhibition of endometrium in the secretory phase and of hyperplastic endometrium treated with progesterone.
Shiozawa T; Nikaido T; Nakayama K; Lu X; Fujii S
Mol Hum Reprod; 1998 Sep; 4(9):899-905. PubMed ID: 9783852
[TBL] [Abstract][Full Text] [Related]
20. PTEN immunohistochemical expression is suppressed in G1 endometrioid adenocarcinoma of the uterine corpus.
Kimura F; Watanabe J; Hata H; Fujisawa T; Kamata Y; Nishimura Y; Jobo T; Kuramoto H
J Cancer Res Clin Oncol; 2004 Mar; 130(3):161-8. PubMed ID: 14689303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
